Literature DB >> 16216093

Evaluation of three pulpotomy medicaments in primary teeth.

D Markovic1, V Zivojinovic, M Vucetic.   

Abstract

AIM: To examine the success of the one-appointment pulpotomy technique with three different medicaments on primary molar teeth.
METHODS: The study was conducted on 104 primary molars in 104 children with an indication for pulpotomy treatment on at least one primary molar. Primary teeth were treated with either formocresol (FC) (34 teeth), calcium hydroxide (CA) (33 teeth) or ferric sulphate (FS) (37 teeth) using standardised criteria for the pulpotomy procedures. Teeth were clinically and radiographically evaluated during the examination period of 18 months.
RESULTS: The clinical success rate at 18 months for the FC and FS groups was 90.9% and 89.2%, respectively. The CA showed an overall clinical success rate of 82.3%, with no statistical difference compared with either the FC or FS groups. The overall radiographic success for each technique was: FC 84.8%, CA 76.5%, and FS 81.1%. The presence of a dentine bridge above the pulp amputation site was observed radiographically for CA (47%), and FS (40.5%) pulpotomies without any statistical difference. Radiographic examination did not reveal the presence of a dentine bridge for any of the teeth treated with FC pulpotomy.
CONCLUSION: Favourable clinical and radiographic success rates of ferric sulphate pulpotomy, comparable to formocresol were obtained. Therefore, ferric sulphate can be recommended as a pulpotomy medicament.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216093

Source DB:  PubMed          Journal:  Eur J Paediatr Dent        ISSN: 1591-996X            Impact factor:   2.231


  23 in total

1.  Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars.

Authors:  Cameron M Zealand; Daniel M Briskie; Tatiana M Botero; James R Boynton; Jan C C Hu
Journal:  Pediatr Dent       Date:  2010 Sep-Oct       Impact factor: 1.874

Review 2.  Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol.

Authors:  E Stringhini Junior; M E B Vitcel; L B Oliveira
Journal:  Eur Arch Paediatr Dent       Date:  2015-04-02

3.  Clinical and radiographic evaluation of the efficacy of sodium hypochlorite as a haemostatic agent compared with physiologic saline on the success of calcium hydroxide pulpotomies in primary molars: an in vivo study.

Authors:  J Nagarathna; S K Srinath; M C Hiremath
Journal:  Eur Arch Paediatr Dent       Date:  2018-10-13

4.  In vivo evaluation of the treatment outcome of pulpotomy in primary molars using diode laser, formocresol, and ferric sulphate.

Authors:  Basak Durmus; Ilknur Tanboga
Journal:  Photomed Laser Surg       Date:  2014-04-09       Impact factor: 2.796

5.  Conventional endodontic treatment of primary molars using metronidazole as an intra-canal medicament: a pilot study.

Authors:  B Kargül; I Tanboga; B Altinok
Journal:  Eur Arch Paediatr Dent       Date:  2010-08

Review 6.  Mineral trioxide aggregate as a pulpotomy medicament: an evidence-based assessment.

Authors:  F K Ng; L B Messer
Journal:  Eur Arch Paediatr Dent       Date:  2008-06

7.  Efficacy of ferric sulphate as a pulpotomy medicament in primary molars: an evidence based approach.

Authors:  S Nuvvula; M Bandi; S K Mallineni
Journal:  Eur Arch Paediatr Dent       Date:  2018-10-19

8.  Comparison of mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars: 42-month follow-up and survival analysis.

Authors:  Sarah E Mettlach; Cameron M Zealand; Tatiana M Botero; James R Boynton; Robert F Majewski; Jan ChingChun Hu
Journal:  Pediatr Dent       Date:  2013 May-Jun       Impact factor: 1.874

Review 9.  Mineral trioxide aggregate as a pulpotomy medicament: a narrative review.

Authors:  F K Ng; L B Messer
Journal:  Eur Arch Paediatr Dent       Date:  2008-03

10.  Knowledge and Practice of Pulp Therapy in Deciduous Teeth among General Dental Practitioners in Saudi Arabia.

Authors:  Ra Togoo; Vs Nasim; M Zakirulla; Sm Yaseen
Journal:  Ann Med Health Sci Res       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.